Cargando…

Central Serous Chorioretinopathy: Treatment with Laser

Currently, no general consensus exists regarding the management of central serous chorioretinopathy (CSC). Laser treatments include three different therapeutic approaches: conventional laser, subthreshold laser and photodynamic therapy. Conventional focal laser, addressed to seal the leaking points,...

Descripción completa

Detalles Bibliográficos
Autores principales: Battaglia Parodi, Maurizio, Arrigo, Alessandro, Iacono, Pierluigi, Falcomatà, Bruno, Bandello, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692124/
https://www.ncbi.nlm.nih.gov/pubmed/33147718
http://dx.doi.org/10.3390/ph13110359
_version_ 1783614438566264832
author Battaglia Parodi, Maurizio
Arrigo, Alessandro
Iacono, Pierluigi
Falcomatà, Bruno
Bandello, Francesco
author_facet Battaglia Parodi, Maurizio
Arrigo, Alessandro
Iacono, Pierluigi
Falcomatà, Bruno
Bandello, Francesco
author_sort Battaglia Parodi, Maurizio
collection PubMed
description Currently, no general consensus exists regarding the management of central serous chorioretinopathy (CSC). Laser treatments include three different therapeutic approaches: conventional laser, subthreshold laser and photodynamic therapy. Conventional focal laser, addressed to seal the leaking points, as evidenced on fluorescein angiography, was largely used in the past, but now, it is almost completely abandoned, owing to the potential complications. Several studies confirmed the positive effects achieved by subthreshold laser treatment in CSC, even though its improper application in the PLACE trial has questioned the effectiveness.
format Online
Article
Text
id pubmed-7692124
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-76921242020-11-28 Central Serous Chorioretinopathy: Treatment with Laser Battaglia Parodi, Maurizio Arrigo, Alessandro Iacono, Pierluigi Falcomatà, Bruno Bandello, Francesco Pharmaceuticals (Basel) Review Currently, no general consensus exists regarding the management of central serous chorioretinopathy (CSC). Laser treatments include three different therapeutic approaches: conventional laser, subthreshold laser and photodynamic therapy. Conventional focal laser, addressed to seal the leaking points, as evidenced on fluorescein angiography, was largely used in the past, but now, it is almost completely abandoned, owing to the potential complications. Several studies confirmed the positive effects achieved by subthreshold laser treatment in CSC, even though its improper application in the PLACE trial has questioned the effectiveness. MDPI 2020-11-02 /pmc/articles/PMC7692124/ /pubmed/33147718 http://dx.doi.org/10.3390/ph13110359 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Battaglia Parodi, Maurizio
Arrigo, Alessandro
Iacono, Pierluigi
Falcomatà, Bruno
Bandello, Francesco
Central Serous Chorioretinopathy: Treatment with Laser
title Central Serous Chorioretinopathy: Treatment with Laser
title_full Central Serous Chorioretinopathy: Treatment with Laser
title_fullStr Central Serous Chorioretinopathy: Treatment with Laser
title_full_unstemmed Central Serous Chorioretinopathy: Treatment with Laser
title_short Central Serous Chorioretinopathy: Treatment with Laser
title_sort central serous chorioretinopathy: treatment with laser
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692124/
https://www.ncbi.nlm.nih.gov/pubmed/33147718
http://dx.doi.org/10.3390/ph13110359
work_keys_str_mv AT battagliaparodimaurizio centralserouschorioretinopathytreatmentwithlaser
AT arrigoalessandro centralserouschorioretinopathytreatmentwithlaser
AT iaconopierluigi centralserouschorioretinopathytreatmentwithlaser
AT falcomatabruno centralserouschorioretinopathytreatmentwithlaser
AT bandellofrancesco centralserouschorioretinopathytreatmentwithlaser